skip top navigation
National Cancer Institute   U.S. National Institutes of Healthwww.cancer.gov
Finland
Finland
ATBC Study

Current Projects

Prostate
Lung
Colorectal
Pancreas
Bladder
Gastric
Esophagus
Renal
Lymphomas/Leukemias
Liver/biliary
Head & neck
Small bowel
Multiple cancer sites
Other endpoints

Prostate Return to top

  • Nitrosamines and prostate cancer
  • Serum insulin and glucose and prostate cancer
  • Post-intervention follow-up of prostate cancer
  • Cohort consortium study of prostate cancer risk, sex steroid hormone metabolism, and IGFs
  • Weight, weight change, and BMI and prostate cancer
  • Dietary carotenoids and retinol and prostate cancer
  • Genes involved in insulin signaling/obesity and insulin resistance and chronic inflammation pathways with prostate cancer (& possibly gallbladder)
  • Genetic variants in genes relevant to energy balance and prostate cancer
  • C-reactive protein and prostate cancer
  • Family history and prostate cancer
  • Genetic polymorphisms in vitamin E transport/metabolism genes, vitamin E supplementation, and prostate cancer
  • Genetic variants in inflammatory and respiratory burst pathway and prostate cancer risk
  • Selenoprotein genetic polymorphisms in relation to prostate cancer risk
  • Phytanic acid, genetic variation in branch-chain fatty acid oxidation pathways, and prostate cancer risk
  • Adipokines and risk of prostate cancer
  • Serum ß-carotene, a-tocopherol, and retinol and prostate cancer survival in the ATBC study
  • The relationship between serum creatinine and prostate cancer

Lung Return to top

  • Post-intervention follow-up of lung cancer
  • P53 mutations (frequency, type, expression of the p53 protein) in lung cancer; Apoptosis and expression of bcl-2 and mcl-1 genes in lung cancer
  • Screening of lung cancer with tumour markers in male smokers with negative chest radiography
  • Biochemical measure of total antioxidant capacity and lung cancer
  • Beta-carotene, lung cancer tissue study
  • Telomere length and lung cancer
  • Family history and lung cancer
  • Lung cancer, smoking history and candidate genes for both
  • Dietary patterns and lung cancer
  • Serum chlamydia and lung cancer
  • Mitocondrial DNA copy number and lung cancer
  • Whole genome scans of lung cancer

Colorectal Return to top

  • NOD2 SNPs and colon cancer
  • Phenolic compounds in serum and the risk of colorectal cancer
  • Polymorphism in metabolic genes (GSTs, NATs) and risk of colorectal cancer
  • Serum and dietary vitamin E and risk of colon cancer
  • Tooth loss and colorectal cancer
  • One-carbon metabolism genetic variants in relation to colorectal cancer risk.
  • Serum factors related to one-carbon metabolism and risk of colorectal cancer

Pancreas Return to top

  • Pancreatitis polymorphisms and pancreatic cancer
  • Insulin pathway polymorphisms and cox and inflammation and DNA repair & carcinogenic metabolism polymorphisms and pancreatic cancer
  • BMI, adiponectin, c-peptide, CPR and (leptin) and pancreatic cancer
  • Whole diet & pancreatic cancer
  • Baseline serum carotenoids, retinol, alpha-tocopherol & pancreatic cancer
  • Cox polymorphisms and pancreatic cancer
  • Proteomics and pancreatic cancer
  • Polymorphisms in folate, selenium and pancreatic cancer
  • Telomere length and pancreatic cancer
  • Whole genome scan pancreatic cancer in consortium
  • Serum pepsinogen and pancreatic cancer
  • Uracil misincorporation, global methylation, p53 strand breaks and pancreatic cancer
  • Helicobacter species
  • Markers of oxidative stress
  • TGF-beta
  • Methylation markers for risk prediction
  • Plasma levels of advanced glycation end product and soluble receptor for advanced glycation end product and risk of pancreatic cancer
  • Mitocondrial DNA copy number and pancreatic cancer
  • Obesity and risk of pancreatic cancer in a pooled stydy of NCI-DCEG cohorts

Bladder Return to top

  • Aromatic amine hemoglobin adducts (from RBCs or whole blood) and serum PAH-albumin adducts and bladder cancer
  • Whole genome scan of bladder cancer

Gastric Return to top

  • Serum pepsinogen and risk of gastric cardia and non-cardia cancers: A prospective study
  • Serum ghrelin and gastric cancer
  • Serum ferritin, transferrin, and CRP and gastric cancer

Esophagus Return to top

  • Serum vitamin E and esophageal cancer in ATBC
  • Serum factors related to one-carbon metabolism and risk of stomach and esophageal cancer
  • Serum ghrelin and espophageal cancer
  • Serum ferritin, transferrin, and CRP and esophageal cancer

Renal Return to top

  • Serum IGF-1 and IGFBP-3 and renal cell cancer
  • Dietary vitamin D and renal cell carcinoma
  • Serum insulin and glucose and renal cell carcinoma
  • Antioxidants, fruits and vegetables in relation to renal cell cancer
  • BMI, hypertension, dietary intake, and renal cancer
  • Vitamin D (serum and genetics) and renal cell carcinoma
  • Serum factors related to one-carbon metabolism and risk of kidney cancer
  • Heavy metal exposure and renal cell carcinoma
  • Association of SNPs in genes in VHL-HIF Pathway and susceptibility of kidney cancer (iSelect)
  • Flavonoid intake and the risk of renal cell carcinoma
  • GWAS of kidney cancer

Lymphomas/Leukemias Return to top

  • Immunological markers and multiple myeloma (also including genetic polymorphisms)
  • Physical activity and NHL
  • Genetic variations in MTHFR, TYMS, SHMT1, MTR, and MTRR and risk of lymphoid cancers
  • Serum indicators of folate, B12, B6, homocysteine and risk of lymphoid cancers
  • Telomere length and hematopoietic cancer
  • Serum vitamin D and lymphoma
  • Serum IGF, insulin, glucose and lymphoma
  • Genomic DNA methylation and lymphoma
  • Mitocondrial DNA copy number and hematopoietic cancer

Liver/biliary Return to top

  • Insulin, glucose and liver and biliary cancer
  • Serum factors related to one-carbon metabolism and risk liver/biliary cancer
  • Diet (antioxidants, fruits, vegetables) and laryngeal cancer
  • HPV-16, HSV-1 and head and neck cancers
  • Serum factors related to one-carbon metabolism and risk of oropharynx/larynx cancers
  • Tooth loss and head and neck cancer

Small bowel Return to top

  • Meat and fat intake and small bowel cancer

Multiple cancer sites Return to top

  • Height and risk of cancer
  • Genetic factors related to one-carbon metabolism and risk of other cancers (colorectal, stomach, kidney, liver, biliary, oropharynx, bladder, pancreas)
  • Retrospective and prospective risk assessments for serum nutrients and cancer (lung, GI, prostate)
  • Serum carotenoids and risk of cancers of the lung, prostate, bladder, colon, rectum, stomach
  • Comparison of prospective and retrospective data in lung
  • Toenail selenium concentration in relation to risk of prostate, colorectal, and other cancers
  • Serum vitamin D and risk of several cancers (renal, pancreatic, lymphoma, stomach, esophagus, prostate, melanoma, larynx, liver/biliary, oropharynx, bladder, colorectal, lung, prostate)
  • Tooth loss and all cancers in the ATBC study

Other endpoints Return to top

  • Carotenoids and total mortality
  • Amyotrophic lateral sclerosis, intervention, dietary factors, and serum micronutrients
  • Heavy metals and cardiovascular disease
  • Effect of alpha-tocopherol and beta-carotene supplements on, and risk factors of diabetes
  • Alcohol consumption, ADH3 polymorphisms, and all-cause mortality
  • Dietary patterns and the risk of cardiovascular disease
  • Glycemic index and the risk of cardiovascular disease
  • Glycemic index and the risk of diabetes
  • Intake of iron and iron status and the risk of coronary heart disease
  • Effect of alpha-tocopherol and beta-carotene supplements on neurologic disorders (dementia, Parkinsons disease, and multiple sclerosis)
  • Cross-sectional study of physical activity and biological markers (IGF-1, IGFBP-3, insulin, total testosterone, free testosterone, dihydrotestosterone, androstenedione, DHEAS, androstanediol glucuronide, estradiol, estrone, and SHBG)
  • Determinants of serum alpha- and gamma-tocopherol levels
  • Hazard analysis of smoking cessation relapse
  • Hazard analysis of smoking abstinence
  • Smoking cessation, medical and smoking history, and neurotransmitter variants
  • Predictors of serum vitamin D
  • Tooth loss and CHD death and total mortality
  • CGEMS added value
  • The joint modeling of smoking pattern and chronic disease
  • GWAS marker predictors of micronutrient, anthropometric, and other biometric measures
 
National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov